Krysanov, I. S., Krysanova, V. S., & Ermakova, V. Y. (2021). Clinical and economic justification of screening for mucopolysaccharidosis type I in children at groups of risks. Качественная клиническая практика, 3, 4. https://doi.org/10.37489/2588-0519-2021-3-4-15
Chicago-referens (17:e uppl.)Krysanov, I. S., V. S. Krysanova, och V. Yu Ermakova. "Clinical and Economic Justification of Screening for Mucopolysaccharidosis Type I in Children at Groups of Risks." Качественная клиническая практика 3 (2021): 4. https://doi.org/10.37489/2588-0519-2021-3-4-15.
MLA-referens (9:e uppl.)Krysanov, I. S., et al. "Clinical and Economic Justification of Screening for Mucopolysaccharidosis Type I in Children at Groups of Risks." Качественная клиническая практика, 3, 2021, p. 4, https://doi.org/10.37489/2588-0519-2021-3-4-15.
